MORGAN STANLEY - CANDEL THERAPEUTICS INC ownership

CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 26 filers reported holding CANDEL THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CANDEL THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$165
-99.0%
92
-98.3%
0.00%
Q3 2022$17,000
+13.3%
5,280
+14.3%
0.00%
Q2 2022$15,000
-37.5%
4,621
-0.6%
0.00%
Q1 2022$24,000
-33.3%
4,651
-1.5%
0.00%
Q4 2021$36,0004,7220.00%
Other shareholders
CANDEL THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Northpond Ventures, LLC 1,935,215$3,464,0351.88%
Sands Capital Ventures, LLC 811,737$1,4530.40%
Empirical Asset Management, LLC 12,000$21,4800.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,700$237,5330.01%
Ergoteles LLC 26,114$46,7440.00%
FRANKLIN RESOURCES INC 1,125,000$2,013,7500.00%
Tower Research Capital LLC (TRC) 7,214$130.00%
WELLS FARGO & COMPANY/MN 98$1750.00%
NORTHERN TRUST CORP 14,483$25,9250.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CANDEL THERAPEUTICS INC shareholders